The role of diabetes in cardiomyopathies of different etiologies-Characteristics and 1-year follow-up results of the EVITA-HF registry

PloS One
Christine MeindlBernhard Unsöld

Abstract

Type 2 diabetes is a major risk factor for cardiovascular diseases, e.g. coronary artery disease (CAD). But it has also been shown that diabetes can cause heart failure independently of ischemic heart disease (IHD) by causing diabetic cardiomyopathy. In contrast to diabetes and IHD, limited data exist regarding patients with diabetes and dilated cardiomyopathy (DCM). EVIdence based TreAtment in Heart Failure (EVITA-HF) comprises web-based case report data on demography, diagnostic measures, adverse events and 1-year follow-up of patients hospitalized for chronic heart failure and an ejection fraction ≤40%. In the present study we focused on the results of patients with diabetes and heart failure. Between February 2009 and November 2015, 4101 patients with chronic heart failure were included in 16 tertiary care centers in Germany. The mortality in patients with diabetes and DCM (n = 323) was more than double (15.2%) than that of DCM patients without diabetes (6.5%, p<0.001, n = 885). In contrast the mortality rate of patients with IHD was not influenced by the presence of diabetes (17.6% in patients with IHD and diabetes n = 945, vs. 14.7% in patients with IHD and no diabetes, n = 1236, p = 0.061). The results also remained stab...Continue Reading

References

Nov 8, 1972·The American Journal of Cardiology·S RublerA Grishman
May 12, 2005·European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology·R ValleL Milani
Jun 1, 2005·Lancet·John J V McMurray, Marc A Pfeffer
Oct 19, 2006·Journal of the American College of Cardiology·Maurizio Galderisi
Jun 27, 2007·Circulation·Sihem Boudina, E Dale Abel
Feb 26, 2008·European Journal of Heart Failure·Cecilia FantoniAngelo Auricchio
May 10, 2013·The New England Journal of Medicine·Augustine M K ChoiBeth Levine
May 10, 2013·The New England Journal of Medicine·Andrea DoriaLeonardo Punzi
Sep 2, 2014·The New England Journal of Medicine·John J V McMurrayUNKNOWN PARADIGM-HF Investigators and Committees
Mar 18, 2015·Circulation·Ryan A Frieler, Richard M Mortensen
Mar 31, 2015·Circulation Research·Douglas L Mann
Apr 19, 2015·European Heart Journal·Petar M Seferović, Walter J Paulus
Sep 18, 2015·The New England Journal of Medicine·Bernard ZinmanUNKNOWN EMPA-REG OUTCOME Investigators
Jun 25, 2016·Circulation Research·Sumanth D Prabhu, Nikolaos G Frangogiannis
Mar 24, 2018·Diabetology & Metabolic Syndrome·Thiago HuebMartino Martinelli Filho
Oct 18, 2018·European Journal of Heart Failure·Steffen PabelSamuel Sossalla
Sep 20, 2019·The New England Journal of Medicine·John J V McMurrayUNKNOWN DAPA-HF Trial Committees and Investigators

❮ Previous
Next ❯

Citations

Dec 5, 2020·The Canadian Journal of Cardiology·Varinder Kaur RandhawaKim A Connelly

❮ Previous
Next ❯

Methods Mentioned

BETA
glycosylation

Software Mentioned

EVITA
SAS
HF

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.